Lixia Zong
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: The TNK-PLUS Randomized Clinical Trial.
Journal: JAMA
Published: May 08, 2026
Engineering AaADH1 for enhanced catalytic efficiency and solubility via substrate tunnel modulation.
Engineering AaADH1 for enhanced catalytic efficiency and solubility via substrate tunnel modulation.
Journal: Enzyme and microbial technology
Published: May 07, 2026
Infarct growth rate and tenecteplase benefit in ischemic stroke at 4.5 to 24 h without thrombectomy-A secondary analysis of the TRACE-III randomized trial.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: April 07, 2026
Infarct Growth Rate and Tenecteplase Benefit in Ischemic Stroke at 4.5 to 24 Hours Without Thrombectomy --A Secondary Analysis of the TRACE-Ⅲ Randomized Trial.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: April 07, 2026
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial.
Journal: Lancet (London, England)
Published: November 06, 2025
Renal dysfunction and outcomes for thrombolysis-treated stroke beyond 4.5 hours: Trace-Ⅲ post hoc analysis.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: April 01, 2025
Deep learning-driven semi-rational design in phenylalanine ammonia-lyase for enhanced catalytic efficiency.
Journal: International journal of biological macromolecules
Published: October 11, 2024
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.
Journal: The New England journal of medicine
Published: June 17, 2024
Rationale and design of a stepped wedge cluster randomised trial to improve acute reperfusion treatment quality for stroke: IMPROVE stroke care in China.
Journal: Stroke and vascular neurology
Published: December 09, 2021
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population.
Journal: Stroke and vascular neurology
Published: April 01, 2020
Cerebral small vessel disease or intracranial large vessel atherosclerosis may carry different risk for future strokes.
Journal: Stroke and vascular neurology
Published: November 12, 2019
Last Updated: 09/26/2026